Summary
Quest Diagnostics Incorporated (DGX) filed an 8-K on May 9, 2011, to report a significant development regarding a civil lawsuit. The company announced an agreement in principle to settle a lawsuit originally filed by a California competitor, with the State of California having intervened. This settlement is material as it resulted in a substantial pre-tax charge of $236 million, or $195 million after tax, which translates to $1.19 per diluted share. This charge impacts the company's financial results for the quarter ended March 31, 2011, and revises previously disclosed figures. Investors should note this charge as it affects profitability and may have implications for future financial performance and strategic outlook. The company is providing updated financial information due to this settlement. While the details of the lawsuit and the specific terms of the settlement are not fully elaborated in this 8-K, the magnitude of the charge indicates a significant legal and financial event for Quest Diagnostics. The filing serves as a notification of this material event and its immediate financial impact, prompting investors to re-evaluate the company's recent performance in light of this new information.
Key Highlights
- 1Quest Diagnostics reached an agreement in principle to settle a civil lawsuit involving a California competitor and the State of California.
- 2The settlement necessitates a pre-tax charge of $236 million.
- 3The after-tax impact of the settlement charge is $195 million.
- 4This charge amounts to $1.19 per diluted share, significantly impacting earnings.
- 5The charge is recorded in the results for the quarter ended March 31, 2011.
- 6This filing updates financial results previously disclosed on April 20, 2011.
- 7The company has attached the press release announcing this settlement as an exhibit.